+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products: 2021-2026

  • ID: 5351734
  • Report
  • June 2021
  • Region: Global
  • 213 pages
  • BCC Research

FEATURED COMPANIES

  • 3M Healthcare
  • Belimed
  • Merck
  • Pfizer
  • Sanofi Pasteur
  • Sterigenics
The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g., catheters, patient ventilation devices, sterile IV filters) that prevent the occurrence of nosocomial infections.



Within each type of treatment, regional analyses will focus on the Americas (i.e., Canada, the U.S., Mexico, Central America and South America), EMRA (i.e., Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e., Japan, China, India, other Western Pacific countries such as Australia and New Zealand, and other Southeast Asian countries).

The Report Includes:
  • 72 tables
  • An updated review of the global healthcare-acquired infection (HCAI)-control market
  • Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of select antimicrobials drugs and environment sterilization/disinfection products currently used or under development for treatment of healthcare-associated infections
  • Market outlook and forecast trends of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent the occurrence of nosocomial infections
  • Estimation of the market size and revenue forecasts for HCAI-control market, and corresponding market share analysis by key market segments - technology type, application, and geography
  • Discussion of the key market dynamics, industry structure, regulatory approval, market deterrents, unmet needs and other factors driving opportunities in microbiology research
  • A look at the pipeline products for antimicrobial resistance (AMR), hospital surveillance methods and tools used to control HCAI infections
  • Review of the U.S. patent grants for innovations in infectious diseases control and viral infections
  • Profile descriptions of the leading industry players including 3M, Merck, Novartis’, Pfizer, Roche, and Sanofi
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Healthcare
  • Belimed
  • Merck
  • Pfizer
  • Sanofi Pasteur
  • Sterigenics
Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports
Chapter 2 Summary and Highlights

Chapter 3 Overview
  • Healthcare-Acquired Infections
  • Types of Infections
  • Central-Line-Associated Bloodstream Infections
  • Surgical Site Infections
  • Catheter-Associated Urinary Tract Infections
  • Ventilator-Associated Pneumonia
  • Diseases and Infectious Agents in Healthcare Settings
  • Acinetobacter
  • Burkholderia Cepacia
  • Clostridium Difficile
  • Clostridium Sordellii
  • Enterobacteriaceae (Carbapenem-Resistant)
  • Gram-Negative Bacteria
  • Hepatitis
  • HIV/AIDS
  • Influenza
  • Klebsiella
  • Methicillin-Resistant Staphylococcus aureus
  • Mycobacterium Abscessus
  • Norovirus
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Vancomycin-Resistant Enterococci
  • Incidence and Prevalence
  • Risk Factors
  • Prevention Strategies
  • Basic Infection Prevention and Control
  • Antibiotics and Multidrug-Resistant Organisms
  • Device-Associated Infection Control
  • Procedure-Associated Guidelines
  • Setting Specific Guidelines
  • WHO Guidelines
  • Surveillance Systems
Chapter 4 Market Summary and Analysis
  • Global Market for Infection Control
  • Regional Analysis
  • Market Drivers
  • Antimicrobial Resistance
  • Increasing Population and Demographic Changes
  • Emerging Markets
  • New Technologies
  • Vaccine Coverage
  • Increase in Focus on HCAIs
  • Market Deterrents
  • Cost-Effectiveness of Newer Methods
  • Unmet Needs
  • Effective Treatment for "Superbugs"
Chapter 5 Pharmaceuticals
  • HCAI Pharmaceutical Market
  • Antibiotics
  • Mechanism of Action
  • Antibiotic Resistance
  • Mechanisms of Antibiotic Resistance
  • Reasons for Antibiotic Resistance
  • Antimicrobial Resistance (Antibiotics): Incidence
  • Antibiotic Resistance: Hospitals and Healthcare Settings
  • Davos Declaration for Combating Antimicrobial Resistance
  • Antibiotics for Bacterial HCAIs
  • Select Marketed Antibiotics
  • Global Market for Antibiotics
  • Antifungal Drugs
  • Antifungals for HCAI
  • Select Marketed Antifungals
  • Global Market for Antifungals
  • Antivirals and Vaccines
  • Hepatitis B and Hepatitis C
  • Influenza
Chapter 6 Environmental Treatment
  • HCAI: Environmental Treatment Market
  • Disinfectants
  • Types
  • Key Marketed Hospital-Use Disinfectants
  • Patient Skin Preparation
  • Key Marketed Patient Skin Preparation Antiseptics
  • Patient Skin Preparation Market
  • Environment Sterilization
  • Air Treatment
  • Room Filtration Systems
  • Room Pressurization
  • UV Light Disinfection
  • Water Treatment
  • Equipment/Facility Sterilization
  • Heat Sterilization
  • Chemical Sterilization
  • Radiation-Based Sterilization
  • Environment Sterilization Market
Chapter 7 Medical Devices
  • HCAI Medical Device Market
  • Antimicrobial Coatings
  • Catheters
  • Patient Ventilation Devices
  • Types
  • Treatments and Devices
  • IV Filters
  • IV Filter Market
Chapter 8 Industry Structure
  • Industry Structure for Healthcare Infection Prevention
  • Suppliers
  • Customers
  • Consumers
Chapter 9 Research and Opportunities
  • New Technologies
  • Hand Hygiene
  • Patient Tracing
  • Self-Disinfecting Surfaces
  • Automated Decontamination Technologies
  • Smart Systems and Predictive Analytics
  • Other Technologies
  • Antibiotics Pipeline
  • Viral Infection Pipeline: Hepatitis B Treatments
  • Pipeline of Viral Infection Influenza Treatments
  • Fungal Infection Treatment Pipeline
Chapter 10 Patent/Patent Application Analysis
  • Pharmaceuticals
  • Antibiotics
  • Hepatitis B Treatments
  • Hepatitis C Treatments
  • Influenza Treatments
  • Antifungal Treatments
  • Environment Sterilization
  • Disinfectants
  • Patient Skin Preparation Treatments
  • Air Treatment Technologies
  • Water Treatment Technologies
  • Medical Devices
  • Catheters and Endotracheal Tubes
  • IV Filters (In-Line)
Chapter 11 Company Profiles
  • Pharmaceutical Companies
  • Gilead Sciences
  • Merck
  • Novartis
  • Pfizer
  • Roche
  • Sanofi Pasteur
  • Seqirus
  • Companies In Sterilization/Disinfection Industry
  • 3M Healthcare
  • Advanced Sterilization Products
  • Becton, Dickinson And Company
  • Belimed
  • The Clorox Company
  • Sterigenics
  • Xenex Disinfection Services
  • Medical Device Companies
  • Bactiguard
  • Teleflex
Chapter 12 Appendix

List of Tables
Summary Table B: Global Market for HCAI Control, by Region, Through 2026
Summary Table A: Global Market for HCAI Control, by Segment, Through 2026
Table 1: Pooled Cumulative Incidence of HCAI and Device-Associated Infections in Adults, 1995-2010
Table 2: HCAIs, LTACHs and IRFs in the U.S., 2019
Table 3: SSI Rates for Select Procedures, U.S., 2019
Table 4: Sterilization and Disinfection Methods, CDC Guidelines, Updated February 2017
Table 5: Air-Handling Systems in Healthcare, CDC Recommendations, Updated February 2017
Table 6: Controlling Spread of Waterborne Infections, CDC Recommendations, Updated February 2017
Table 7: Routine Prevention of Waterborne Microbial Contamination within the Distribution System, CDC Recommendations, Updated February 2017
Table 8: Proportion of Resistant Strains, by WHO Region
Table 9: WHO Priority List, Pathogens for R&D of New Antibiotics
Table 10: Administrative Measures, MDROs, CDC Recommendations, Updated 2006
Table 11: Education and Training, MDROs, CDC Recommendations, Updated 2006
Table 12: Judicious Use of Antimicrobial Agents, MDROs, CDC Recommendations, Updated 2006
Table 13: Surveillance, MDROs, CDC Recommendations, Updated 2006
Table 14: Appropriate Urinary Catheter Use, CDC Recommendations, Updated 2009
Table 15: Urinary Catheter Maintenance, CDC Recommendations, Updated 2009
Table 16: Summary of Recommendations, CRBSI, CDC, Updated 2011
Table 17: SSI, CDC Recommendations, Updated 2017
Table 18: Dialysis, CDC Recommendations, Updated 2016
Table 19: Core Components of IPC Programs at the National and Acute Healthcare Facility Level, HCAIs, WHO Recommendations, Updated 2016
Table 20: Surveillance Elements and Methodology, CDC, Updated 2006
Table 21: Global Market for HCAI Control, by Segment, Through 2026
Table 22: Global Market for HCAI Control, by Region, Through 2026
Table 23: Global Market for HCAI Pharmaceuticals, by Category, Through 2026
Table 24: Proportion of Resistant Strains, by WHO Region
Table 25: WHO Priority List, Pathogens for R&D of New Antibiotics
Table 26: Select Branded Antibiotics, by Manufacturer
Table 27: Global Market for HCAI Antibiotics, by Class (ATC Code), Through 2026
Table 28: Global Market for HCAI Antibiotics, by Region, Through 2026
Table 29: Select Branded Antifungals, by Manufacturer
Table 30: Global Market for HCAI Antifungals, by Class, Through 2026
Table 31: Global Market for HCAI Antifungals, by Region, Through 2026
Table 32: Key Marketed Hepatitis B Drugs
Table 33: Global Market for Hepatitis B Therapeutics for HCAIs, by Region, Through 2026
Table 34: Global Market for Hepatitis B Vaccines for HCAIs, by Region, Through 2026
Table 35: Key Marketed Hepatitis C Drugs
Table 36: Global Market for Hepatitis C Therapeutics for HCAIs, by Region, Through 2026
Table 37: Key Marketed Influenza Vaccines
Table 38: Key Marketed Antivirals for Influenza
Table 39: Global Market for Influenza Vaccines for HCAIs, by Region, Through 2026
Table 40: Global Market for HCAI Environment Treatment, by Category, Through 2026
Table 41: Select Branded Disinfectants, by Manufacturer
Table 42: Global Market for Disinfectant in Hospitals, by Region, Through 2026
Table 43: Select Branded Skin Antiseptics (Preoperative Care), by Manufacturer
Table 44: Global Market for Presurgical Skin Preparation, by Region, Through 2026
Table 45: Global Market for Air-Filtration in Hospitals, by Region, Through 2026
Table 46: Global Market for High-Temperature Sterilization, by Region, Through 2026
Table 47: Global Market for Low-Temperature Sterilization, by Category, Through 2026
Table 48: Global Market for Low-Temperature Sterilization, by Region, Through 2026
Table 49: Global Market for Radiation-Based Sterilization, by Category, Through 2026
Table 50: Global Market for Radiation-Based Sterilization, by Region, Through 2026
Table 51: Global Market for HCAI Medical Devices, by Category, Through 2026
Table 52: Global Market for Coated Catheters, by Category, Through 2026
Table 53: Global Market for Coated Catheters, by Region, Through 2026
Table 54: Global Market for Coated Endotracheal Tube, by Region, Through 2026
Table 55: Global Market for IV Filters by Region, Through 2026
Table 56: Global Antibiotics Development Pipeline
Table 57: Hepatitis B and Hepatitis C Clinical Pipeline
Table 58: Influenza A and Influenza B Clinical Pipeline
Table 59: Antifungal Clinical Pipeline
Table 60: Number of Patents/Patent Applications on Antibiotics, 2014-2019
Table 61: Number of Patents/Patent Applications on Hepatitis B Treatments, 2014-2019
Table 62: Number of Patents/Patent Applications on Hepatitis C Treatments, 2014-2019
Table 63: Number of Patents/Patent Applications on Influenza Treatments, 2014-2019
Table 64: Number of Patents/Patent Applications on Antifungal Treatments, 2014-2019
Table 65: Number of Patents/Patent Applications on Disinfectants, 2014-2019
Table 66: Number of Patents/Patent Applications on Patient Skin Preparation Treatments, 2014-2019
Table 67: Number of Patents/Patent Applications on Air Treatment, 2014-2019
Table 68: Number of Patents/Patent Applications on Water Treatment, 2014-2019
Table 69: Number of Patents/Patent Applications on Catheters and ETTs, 2014-2019
Table 70: Acronyms Used in This Report
Table 71: Glossary of Terms Used in Global Markets for Infectious Diseases
Table 72: Report Sources

List of Figures
Summary Figure A: Global Market for HCAI Control, by Segment, 2020-2026
Summary Figure B: Global Market for HCAI Control, by Region, 2020-2026
Figure 1: Antibiotic Use* by Class, Select Classes, 2010 and 2015
Figure 2: Global Market for HCAI Control, by Segment, 2020-2026
Figure 3: Global Market for HCAI Control, by Region, 2020-2026
Figure 4: Global Market for HCAI Pharmaceuticals, by Category, 2020-2026
Figure 5: Antibiotic Use* by Class, Select Classes, 2000 and 2010
Figure 6: Global Market for HCAI Antibiotics, by Class (ATC Code), 2020-2026
Figure 7: Global Market for HCAI Antibiotics, by Region, 2020-2026
Figure 8: Global Market for HCAI Antifungals, by Class, 2020-2026
Figure 9: Global Market for HCAI Antifungals, by Region, 2020-2026
Figure 10: Global Market for Hepatitis B Therapeutics for HCAIs by Region, 2020-2026
Figure 11: Global Market for Hepatitis B Vaccines for HCAIs, by Region, 2020-2026
Figure 12: Global Market for Hepatitis C Therapeutics for HCAIs, by Region, 2020-2026
Figure 13: Global Market for Influenza Vaccines for HCAIs, by Region, 2020-2026
Figure 14: Global Market for HCAI Environment Treatment, by Category, 2020-2026
Figure 15: Global Market for Disinfectant Use in Hospitals, by Region, 2020-2026
Figure 16: Global Market for Presurgical Skin Preparation, by Region, 2020-2026
Figure 17: Global Market for Air-Filtration inHospitals, by Region, 2020-2026
Figure 18: Global Market for Air-Filtration inHospitals, by Region, 2020-2026
Figure 19: Global Market for Low-Temperature Sterilization, by Category, 2020-2026
Figure 20: Global Market for Low-Temperature Sterilization, by Region, 2020-2026
Figure 21: Global Market for Radiation-Based Sterilization, by Category, 2020-2026
Figure 22: Global Market for Radiation-Based Sterilization, by Region, 2020-2026
Figure 23: Global Market for HCAI Medical Devices, by Category, 2020-2026
Figure 24: Global Market for Coated Catheters, by Category, 2020-2026
Figure 25: Global Market for Coated Catheters, by Region, 2020-2026
Figure 26: Global Market for Coated Endotracheal Tube, by Region, 2020-2026
Figure 27: Global Market for IV Filters, by Region, 2020-2026
Figure 28: HCAI-Prevention Industry Structure
Note: Product cover images may vary from those shown
  • 3M Healthcare
  • Advanced Sterilization Products
  • Bactiguard
  • Becton, Dickinson And Company
  • Belimed
  • Gilead Sciences
  • Merck
  • Novartis
  • Pfizer
  • Roche
  • Sanofi Pasteur
  • Seqirus
  • Sterigenics
  • Teleflex
  • The Clorox Company
  • Xenex Disinfection Services
Note: Product cover images may vary from those shown
Adroll
adroll